MedTrace Logo

Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome

NCT02213172 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2020-03-13

No results posted yet for this study

Summary

The purpose of this study is to determine if two different probiotic strains, Lactobacillus paracasei HA-196 and Bifidobacterium longum R0175, are effective in helping subjects manage the symptoms of IBS

Conditions

  • Irritable Bowel Syndrome

Interventions

DIETARY_SUPPLEMENT

Bifidobacterium longum R0175

DIETARY_SUPPLEMENT

Lactobacillus paracasei HA-196

OTHER

Placebo

Sponsors & Collaborators

  • Lallemand Health Solutions

    collaborator INDUSTRY

  • KGK Science Inc.

    lead INDUSTRY

Principal Investigators

  • Tetyana Pelipyagina, MD · KGK Science Inc.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-30
Primary Completion
2018-02-15
Completion
2018-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213172 on ClinicalTrials.gov